Fig. 6From: MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-αEffects of miR-505 transfection on endometrial adenocarcinoma cell genotype in vitro. miR-505 overexpression reduced TGF-α, CDK2, MMP2 and MMP9 expression, while increased cleaved PARP and Bax mRNA (a) or protein (b) expression. *P < 0.05Back to article page